France Immunoassay- Gamma Counters Market to 2032
Overview
The France Immunoassay- Gamma Counters Market is expected to reach a 4.10 USD Million by 2032 and is projected to grow at a CAGR of 10.53% from 2025 to 2032.
Revenue, 2024 (USD Million)
2.64
Forecast, 2032 (USD Million)
4.10
CAGR, 2024 - 2032
10.53%
Report Coverage
France
France Immunoassay- Gamma Counters Market 2018-2032 USD Million
France Immunoassay- Gamma Counters Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2.64 USD Million
- Projected Market Size (2032): 4.10 USD Million
- CAGR (2025-2032): 10.53%
Key Findings of France Immunoassay- Gamma Counters Market
- The France Immunoassay- Gamma Counters Market was valued at 2.64 USD Million in 2024.
- The France Immunoassay- Gamma Counters Market is likely to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 2.23 USD Million
- The fastest growing segment Infectious Diseases in Disease Condition Segment grew Fastest with a CAGR of 11.48% during the forecast period from 2024 to 2032.
France Immunoassay- Gamma Counters Market Scope
France Immunoassay- Gamma Counters Market Segmentation & Scope
Disease Condition
- Autoimmune Disease
- Cardiac Markers
- Neonatal Screening
- Allergy
- Others
- Endocrine Hormones
- Therapeutic Drug Monitoring
- Infectious Diseases
- Cancer Biomarkers
Purchase Mode
- Rental Purchase
- Outright Purchase
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Blood Banks
- Pharmaceutical And Biotechnology Companies
- Research And Academic Institutes
- Hospitals
- Laboratory
Product Type
- Manual/Semi-Automated
- Automated
Well
- Single-Well
- Multi-Well
Application
- Others
- Nuclear Medicine Assay
- Radio Immunoassays
France Immunoassay- Gamma Counters Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2016 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 2.64 USD Million |
| Market Value in 2032 | 4.10 USD Million |
| CAGR (2025-2032) | 10.53% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease Condition,Purchase Mode,Distribution Channel,End User,Product Type,Well,Application |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 2.64 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 2.64 USD Million in 2024.
Segments and Scope
-
France Immunoassay- Gamma Counters Market to 2032, By Disease Condition
- Cancer Biomarkers is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 0.72 USD Million in the year 2024.
- Infectious Diseases is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 10.10 % in forecast period 2025-2032.
-
France Immunoassay- Gamma Counters Market to 2032, By Purchase Mode
- Outright Purchase is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 1.97 USD Million in the year 2024.
- Outright Purchase is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 10.85 % in forecast period 2025-2032.
-
France Immunoassay- Gamma Counters Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 2.23 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 10.75 % in forecast period 2025-2032.
-
France Immunoassay- Gamma Counters Market to 2032, By End User
- Laboratory is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 0.75 USD Million in the year 2024.
- Laboratory is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 11.26 % in forecast period 2025-2032.
-
France Immunoassay- Gamma Counters Market to 2032, By Product Type
- Automated is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 1.61 USD Million in the year 2024.
- Automated is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 10.83 % in forecast period 2025-2032.
-
France Immunoassay- Gamma Counters Market to 2032, By Well
- Multi-Well is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 1.65 USD Million in the year 2024.
- Multi-Well is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 10.96 % in forecast period 2025-2032.
-
France Immunoassay- Gamma Counters Market to 2032, By Application
- Radio Immunoassays is the largest segment in France Immunoassay- Gamma Counters Market to 2032 with a revenue of 1.41 USD Million in the year 2024.
- Nuclear Medicine Assay is the Fastest growing segment in France Immunoassay- Gamma Counters Market to 2032 with a Growth rate of 10.10 % in forecast period 2025-2032.
France Immunoassay- Gamma Counters Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| LabLogic Systems Ltd. | |||
| SHIN JIN MEDICS INC. | |||
| Berthold Technologies GmbH & Co.KG | |||
| Hidex Oy | |||
France Immunoassay- Gamma Counters Market Geographical Sales Distribution, 2018-2032 USD Million
France Immunoassay- Gamma Counters Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Immunoassay- Gamma Counters Market is segmented based on Segmentation Disease Condition,Purchase Mode,Distribution Channel,End User,Product Type,Well,Application.
France Immunoassay- Gamma Counters Market was valued at USD 2.64(Revenue in USD Million) in 2016.
France Immunoassay- Gamma Counters Market is projected to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the France Immunoassay- Gamma Counters Market, holding a largest market share of 2.23 USD Million in 2024
France Immunoassay- Gamma Counters Market Scope
France Immunoassay- Gamma Counters Market Segmentation & Scope
Disease Condition
- Autoimmune Disease
- Cardiac Markers
- Neonatal Screening
- Allergy
- Others
- Endocrine Hormones
- Therapeutic Drug Monitoring
- Infectious Diseases
- Cancer Biomarkers
Purchase Mode
- Rental Purchase
- Outright Purchase
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Blood Banks
- Pharmaceutical And Biotechnology Companies
- Research And Academic Institutes
- Hospitals
- Laboratory
Product Type
- Manual/Semi-Automated
- Automated
Well
- Single-Well
- Multi-Well
Application
- Others
- Nuclear Medicine Assay
- Radio Immunoassays
Frequently Asked Questions
The France Immunoassay- Gamma Counters Market is segmented based on Segmentation Disease Condition,Purchase Mode,Distribution Channel,End User,Product Type,Well,Application.
France Immunoassay- Gamma Counters Market was valued at USD 2.64(Revenue in USD Million) in 2016.
France Immunoassay- Gamma Counters Market is projected to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
The estimated market value of the France Immunoassay- Gamma Counters Market for final year is USD 4.10 (USD Million).
France Immunoassay- Gamma Counters Market Company Profiling
Frequently Asked Questions
The France Immunoassay- Gamma Counters Market is segmented based on Segmentation Disease Condition,Purchase Mode,Distribution Channel,End User,Product Type,Well,Application.
France Immunoassay- Gamma Counters Market was valued at USD 2.64(Revenue in USD Million) in 2016.
France Immunoassay- Gamma Counters Market is projected to grow at a CAGR of 10.53% during the forecast period of 2024 to 2032.
The estimated market value of the France Immunoassay- Gamma Counters Market for final year is USD 4.10 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.